The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Chulkov V.S.

South Ural State Medical University

Syundyukova E.G.

South Ural State Medical University

Chulkov Vl.S.

South Ural State Medical University

Tarasova O.A.

South Ural State Medical University

Romanyugo G.D.

South Ural State Medical University

Hypertensive disorders during pregnancy and risk of cardiovascular disease

Authors:

Chulkov V.S., Syundyukova E.G., Chulkov Vl.S., Tarasova O.A., Romanyugo G.D.

More about the authors

Journal: Russian Journal of Preventive Medicine. 2021;24(12): 97‑104

DOI: 10.17116/profmed20212412197

Views: 7144

Downloaded: 131

Download PDF (RU)
Contact the author
Table of contents

HYPERTENSIVE DISORDERS DURING PREGNANCY AND RISK OF CARDIOVASCULAR DISEASE
HYPERTENSIVE DISORDERS DURING PREGNANCY AND RISK OF CARDIOVASCULAR DISEASE

To cite this article:

Chulkov VS, Syundyukova EG, Chulkov VlS, Tarasova OA, Romanyugo GD. Hypertensive disorders during pregnancy and risk of cardiovascular disease. Russian Journal of Preventive Medicine. 2021;24(12):97‑104. (In Russ.)
https://doi.org/10.17116/profmed20212412197

 
 
 
Подписка 2025-2 (Russian Journal of Preventive Medicine)
 
МСФ на ЯМ
Close metadata
Recommended articles:
The impact of arti­ficial inte­lligence on double reading of mammograms. Russian Journal of Preventive Medi­cine. 2024;(5):32-37
Patients with ischaemic heart disease and non-steroidal anti-inflammatory drugs dosing — reco­mmendations and real-life clinical setting. Russian Journal of Preventive Medi­cine. 2024;(6):68-73
Pathophysiological mechanisms of vascular wall alte­rations in meno­pausal women. Russian Journal of Preventive Medi­cine. 2024;(6):91-97
Methods of cost-effectiveness evaluation of endo­vascular patent fora­men ovale closure for seco­ndary prevention of cryptogenic stroke. Russian Journal of Preventive Medi­cine. 2024;(6):105-110
Topi­cal application of hypo­tensive drugs for the prevention of intraocular pressure elevation after intravitreal inje­ctions of anti-VEGF drugs. Russian Annals of Ophthalmology. 2024;(2-2):73-79
Influence of inte­stinal microbiota on cardiovascular athe­rosclerotic diseases and colo­rectal cancer in elde­rly patients. Rege­nerative Biotechnologies, Preventive, Digi­tal and Predictive Medi­cine. 2024;(1):30-36
Pecu­liarities of local mRNA gene expression of pro- and anti-inflammatory cyto­kines in term pregnancy. Russian Bulletin of Obstetrician-Gynecologist. 2024;(3):6-13
The problem of diabetes mellitus in obstetrics. Russian Bulletin of Obstetrician-Gynecologist. 2024;(3):25-29
Modern approach to the diagnosis of microcirculatory diso­rders in obstetrics. Russian Bulletin of Obstetrician-Gynecologist. 2024;(3):30-35
Rela­tionship between pregnancy and the risk of mali­gnant neoplasms of the female reproductive system. Russian Bulletin of Obstetrician-Gynecologist. 2024;(3):48-54

Cardiovascular disease remains the leading cause of death and morbidity among women. Hypertensive disorders during pregnancy are an interdisciplinary problem that has been studied for many years, but, unfortunately, remains unresolved. The consequences of preeclampsia and other forms of hypertension in pregnant women are quite serious for both the mother and the fetus. The subject of discussion is the question of whether there is a direct association of hypertensive disorders of pregnancy and preeclampsia with the subsequent development of cardiovascular diseases, or whether these conditions have common pathophysiological mechanisms and risk factors. The accumulated data will make it possible to personally identify high-risk groups for the development of hypertensive disorders of pregnancy and preeclampsia, which will be able to improve preventive and therapeutic approaches and develop recommendations for correcting lifestyle at the stage of preparation for pregnancy.

Keywords:

hypertensive disorders of pregnancy
preeclampsia
pregnancy
cardiovascular diseases
polymorphisms
prevention

Authors:

Chulkov V.S.

South Ural State Medical University

Syundyukova E.G.

South Ural State Medical University

Chulkov Vl.S.

South Ural State Medical University

Tarasova O.A.

South Ural State Medical University

Romanyugo G.D.

South Ural State Medical University

Received:

12.07.2021

Accepted:

07.10.2021

List of references:

  1. Brown MA, Magee LA, Kenny LC, Karumanchi SA, McCarthy FP, Saito S, Hall DR, Warren CE, Adoyi G, Ishaku S; International Society for the Study of Hypertension in Pregnancy (ISSHP). The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice. Hypertension. 2018;72(1):24-43.  https://doi.org/10.1161/HYPERTENSIONAHA.117.10803
  2. Diagnosis and treatment of cardiovascular diseases during pregnancy 2018. National guidelines. Russ J Cardiol. 2018;23(7):156-200. (In Russ.). https://doi.org/10.15829/1560-4071-2018-7-156-200
  3. Lisonkova S, Sabr Y, Mayer C, Young C, Skoll A, Joseph KS. Maternal morbidity associated with early-onset and late-onset preeclampsia. Obstet Gynecol. 2014;124:771-781.  https://doi.org/10.1097/AOG.0000000000000472
  4. The main indicators of maternal and child health, the activities of the child protection and obstetric services in the Russian Federation. M. 2018. Accessed July 12, 2021. (In Russ.). https://minzdrav.gov.ru/ministry/61/22/stranitsa-979/statisticheskie-i-informatsionnye-materialy/statisticheskiy-sbornik-2018-god
  5. Vakhtangadze T, Gakhokidze N, Khutsishvili M, Mosidze S. The link between hypertension and preeclampsia/eclampsia-life-long cardiovascular risk for women. Vessel Plus 2019;3:19.  https://doi.org/10.20517/2574-1209.2019.07
  6. Seely EW, Tsigas E, Rich-Edwards JW. Preeclampsia and future cardiovascular disease in women: How good are the data and how can we manage our patients? Semin Perinatol. 2015;39(4):276-283.  https://doi.org/10.1053/j.semperi.2015.05.006
  7. Fox R, Kitt J, Leeson P, Aye CYL, Lewandowski AJ. Preeclampsia: Risk Factors, Diagnosis, Management, and the Cardiovascular Impact on the Offspring. J Clin Med. 2019;8(10):1625. https://doi.org/10.3390/jcm8101625
  8. Baijnath S, Soobryan N, Mackraj I, Gathiram P, Moodley J. The optimization of a chronic nitric oxide synthase (NOS) inhibition model of pre-eclampsia by evaluating physiological changes. Eur J Obstet Gynecol Reprod Biol. 2014;182:71-75.  https://doi.org/10.1016/j.ejogrb.2014.08.021
  9. Powe CE, Levine RJ, Karumanchi SA. Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease. Circulation. 2011;123(24):2856-2869. https://doi.org/10.1161/CIRCULATIONAHA.109.853127
  10. Tomimatsu T, Mimura K, Matsuzaki S, Endo M, Kumasawa K, Kimura T. Preeclampsia: Maternal Systemic Vascular Disorder Caused by Generalized Endothelial Dysfunction Due to Placental Antiangiogenic Factors. Int J Mol Sci. 2019;20(17):4246. https://doi.org/10.3390/ijms20174246
  11. Redman C. The six stages of pre-eclampsia. Pregnancy Hypertens. 2014; 4(3):246.  https://doi.org/10.1016/j.preghy.2014.04.020
  12. Roberts JM, Hubel CA. The two stage model of preeclampsia: variations on the theme. Placenta. 2009;30(suppl A):32-37.  https://doi.org/10.1016/j.placenta.2008.11.009
  13. Burton GJ, Redman CW, Roberts JM, Moffett A. Pre-eclampsia: pathophysiology and clinical implications. BMJ. 2019;366:l2381  https://doi.org/10.1136/bmj.l2381
  14. Williams D. Pregnancy: a stress test for life. Curr Opin Obstet Gynecol. 2003; 15(6):465-471.  https://doi.org/10.1097/00001703-200312000-00002
  15. Verlohren S, Perschel FH, Thilaganathan B, Dröge LA, Henrich W, Busjahn A, Khalil A. Angiogenic Markers and Cardiovascular Indices in the Prediction of Hypertensive Disorders of Pregnancy. Hypertension. 2017;69(6): 1192-1197. https://doi.org/10.1161/HYPERTENSIONAHA.117.09256
  16. Chen CW, Jaffe IZ, Karumanchi SA. Pre-eclampsia and cardiovascular disease. Cardiovasc Res. 2014;101(4):579-586.  https://doi.org/10.1093/cvr/cvu018
  17. Grandi SM, Vallée-Pouliot K, Reynier P, Eberg M, Platt RW, Arel R, Basso O, Filion KB. Hypertensive Disorders in Pregnancy and the Risk of Subsequent Cardiovascular Disease. Paediatr Perinat Epidemiol. 2017;31(5):412-421.  https://doi.org/10.1111/ppe.12388
  18. Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ. 2007;335(7627):974.  https://doi.org/10.1136/bmj.39335.385301.BE
  19. den Ruijter H, Pasterkamp G, Rutten FH, Lam CS, Chi C, Tan KH, van Zonneveld AJ, Spaanderman M, de Kleijn DP. Heart failure with preserved ejection fraction in women: the Dutch Queen of Hearts program. Neth Heart J. 2015;23(2):89-93.  https://doi.org/10.1007/s12471-014-0613-1
  20. Honigberg MC, Zekavat SM, Aragam K, Klarin D, Bhatt DL, Scott NS, Peloso GM, Natarajan P. Long-Term Cardiovascular Risk in Women With Hypertension During Pregnancy. J Am Coll Cardiol. 2019;74(22):2743-2754. https://doi.org/10.1016/j.jacc.2019.09.052
  21. Leon LJ, McCarthy FP, Gonzalez-Izquierdo A, Prieto-Merino D, Casas JP, Chappell L. Preeclampsia and Cardiovascular Disease in a Large UK Pregnancy Cohort of Linked Electronic Health Records: A CALIBER Study. Circulation. 2019;140(13):1050-1060. https://doi.org/10.1161/CIRCULATIONAHA.118.038080
  22. Scheres LJJ, Lijfering WM, Groenewegen NFM, Koole S, de Groot CJM, Middeldorp S, Cannegieter SC. Hypertensive Complications of Pregnancy and Risk of Venous Thromboembolism. Hypertension. 2020;75(3):781-787.  https://doi.org/10.1161/HYPERTENSIONAHA.119.14280.
  23. Cain MA, Salemi JL, Tanner JP, Kirby RS, Salihu HM, Louis JM. Pregnancy as a window to future health: maternal placental syndromes and short-term cardiovascular outcomes. Am J Obstet Gynecol. 2016;215(4):484.e1-484.e14.  https://doi.org/10.1016/j.ajog.2016.05.047
  24. Hromadnikova I, Kotlabova K, Dvorakova L, Krofta L. Maternal Cardiovascular Risk Assessment 3-to-11 Years Postpartum in Relation to Previous Occurrence of Pregnancy-Related Complications. J Clin Med. 2019;8(4):544.  https://doi.org/10.3390/jcm8040544
  25. Perry H, Khalil A, Thilaganathan B. Preeclampsia and the cardiovascular system: An update. Trends Cardiovasc Med. 2018;28(8):505-513.  https://doi.org/10.1016/j.tcm.2018.04.009
  26. Benschop L, Duvekot JJ, Roeters van Lennep JE. Future risk of cardiovascular disease risk factors and events in women after a hypertensive disorder of pregnancy. Heart. 2019;105(16):1273-1278. https://doi.org/10.1136/heartjnl-2018-313453
  27. Langlois AWR, Park AL, Lentz EJM, Ray JG. Preeclampsia Brings the Risk of Premature Cardiovascular Disease in Women Closer to That of Men. Can J Cardiol. 2020;36(1):60-68.  https://doi.org/10.1016/j.cjca.2019.06.028
  28. Burton, GJ, Redman CW, Roberts JM, Moffett A. Pre-eclampsia: pathophysiology and clinical implications. BMJ. 2019;366:l2381. https://doi.org/10.1136/bmj.l2381
  29. Syundyukova EG, Chulkov VS, Ryabikina MG. Preeclampsia: The Modern State of the Problem. Doctor.Ru. 2021;20(1):11-16. (In Russ.). https://doi.org/10.31550/1727-2378-2021-20-1-11-16
  30. Duffy J, Cairns AE, Richards-Doran D, van ‘t Hooft J, Gale C, Brown M, Chappell LC, Grobman WA, Fitzpatrick R, Karumanchi SA, Khalil A, Lucas DN, Magee LA, Mol BW, Stark M, Thangaratinam S, Wilson MJ, von Dadelszen P, Williamson PR, Ziebland S, McManus RJ; International Collaboration to Harmonise Outcomes for Pre-eclampsia (iHOPE). A core outcome set for pre-eclampsia research: an international consensus development study. BJOG: An International Journal of Obstetrics and Gynaecology. 2020;127(12):1516-1526. https://doi.org/10.1111/1471-0528.16319
  31. Miralles F, Collinot H, Boumerdassi Y, Ducat A, Duché A, Renault G, Marchiol C, Lagoutte I, Bertholle C, Andrieu M, Jacques S, Méhats S, Vaiman D. Long-term cardiovascular disorders in the STOX1 mouse model of preeclampsia. Sci Rep. 2019;9(1):11918. https://doi.org/10.1038/s41598-019-48427-3
  32. Tomimatsu T, Mimura K, Matsuzaki S, Endo M, Kumasawa K, Kimura T. Preeclampsia: Maternal Systemic Vascular Disorder Caused by Generalized Endothelial Dysfunction Due to Placental Antiangiogenic Factors. Int J Mol Sci. 2019;20(17):4246. https://doi.org/10.3390/ijms20174246.
  33. Pankiewicz K, Szczerba E, Maciejewski T, Fijałkowska A. Non-obstetric complications in preeclampsia. Prz Menopauzalny. 2019;18(2):99-109.  https://doi.org/10.5114/pm.2019.85785
  34. Su H, Lei CT, Zhang C. Interleukin-6 Signaling Pathway and Its Role in Kidney Disease: An Update. Front Immunol. 2017;8:405.  https://doi.org/10.3389/fimmu.2017.00405
  35. Pinheiro MB, Martins-Filho OA, Mota AP, Alpoim PN, Godoi LC, Silveira AC, Teixeira-Carvalho A, Gomes KB, Dusse LM. Severe preeclampsia goes along with a cytokine network disturbance towards a systemic inflammatory state. Cytokine. 2013;62(1):165-173.  https://doi.org/10.1016/j.cyto.2013.02.027
  36. Muijsers, HEC, Roeleveld N, van der Heijden, OWH, Maas AHEM. Consider Preeclampsia as a First Cardiovascular Event. Curr Cardiovasc Risk Rep. 2019;13:21.  https://doi.org/10.1007/s12170-019-0614-0
  37. van Rijn BB, Bruinse HW, Veerbeek JH, Post Uiterweer ED, Koenen SV, van der Bom JG, Rijkers GT, Roest M, Franx A. Postpartum Circulating Markers of Inflammation and the Systemic Acute-Phase Response After Early-Onset Preeclampsia. Hypertension. 2016;67(2):404-414.  https://doi.org/10.1161/HYPERTENSIONAHA.115.06455
  38. Häupl T, Zimmermann M, Kalus U, Yürek S, Koscielny J, Hoppe B. Angiotensin converting enzyme intron 16 insertion/deletion genotype is associated with plasma C-reactive protein concentration in uteroplacental dysfunction. J Renin Angiotensin Aldosterone Syst. 2015;16(2):422-427.  https://doi.org/10.1177/1470320314539181
  39. Mattina GF, Van Lieshout RJ, Steiner M. Inflammation, depression and cardiovascular disease in women: the role of the immune system across critical reproductive events. Ther Adv Cardiovasc Dis. 2019;13:1753944719851950. https://doi.org/10.1177/1753944719851950
  40. Pritchard S, Wick HC, Slonim DK, Johnson KL, Bianchi DW. Comprehensive Analysis of Genes Expressed by Rare Microchimeric Fetal Cells in the Maternal Mouse Lung. Biology of Reproduction. 2012;87(2):42.  https://doi.org/10.1095/biolreprod.112.101147
  41. Kirollos S, Skilton M, Patel S, Arnott C. A Systematic Review of Vascular Structure and Function in Pre-eclampsia: Non-invasive Assessment and Mechanistic Links. Front Cardiovasc Med. 2019;6:166.  https://doi.org/10.3389/fcvm.2019.00166
  42. Tarasova OA, Chulkov VS, Sinitsyn SP, Vereina NK, Chulkov VlS. Risk factors for cardiovascular complications in women with hypertensive disorders during pregnancy. Arterial Hypertension. 2019;25(1):97-104. (In Russ.). https://doi.org/10.18705/1607-419X-2019-25-1-97-104
  43. Wotherspoon AC, Young IS, McCance DR, Patterson CC, Maresh MJ, Pearson DW, Walker JD, Holmes VA; Diabetes and Pre-eclampsia Intervention Trial (DAPIT) Study Group. Serum Fatty Acid Binding Protein 4 (FABP4) Predicts Pre-eclampsia in Women With Type 1 Diabetes. Diabetes Care. 2016;39(10):1827-1829. https://doi.org/10.2337/dc16-0803
  44. Davis EF, Lazdam M, Lewandowski AJ, Worton SA, Kelly B, Kenworthy Y, Adwani S, Wilkinson AR, McCormick K, Sargent I, Redman C, Leeson P. Cardiovascular risk factors in children and young adults born to preeclamptic pregnancies: a systematic review. Pediatrics. 2012;129(6):1552-1561. https://doi.org/10.1542/peds.2011-3093
  45. Stojanovska V, Scherjon SA, Plösch T. Preeclampsia As Modulator of Offspring Health. Biol Reprod. 2016;94(3):53.  https://doi.org/10.1095/biolreprod.115.135780
  46. Perry H, Khalil A, Thilaganathan B. Preeclampsia and the cardiovascular system: An update. Trends Cardiovasc Med. 2018;28(8):505-513.  https://doi.org/10.1016/j.tcm.2018.04.009
  47. Hakim J, Senterman MK, Hakim AM. Preeclampsia is a biomarker for vascular disease in both mother and child: the need for a medical alert system. Int J Pediatr. 2013;2013:953150. https://doi.org/10.1155/2013/953150.
  48. Youssef L, Miranda J, Paules C, Garcia-Otero L, Vellvé K, Kalapotharakos G, Sepulveda-Martinez A, Crovetto F, Gomez O, Gratacós E, Crispi F. Fetal cardiac remodeling and dysfunction is associated with both preeclampsia and fetal growth restriction. Am J Obstet Gynecol. 2020;222(1):79.e1-79.e9.  https://doi.org/10.1016/j.ajog.2019.07.025
  49. Lu HQ, Hu R. Lasting Effects of Intrauterine Exposure to Preeclampsia on Offspring and the Underlying Mechanism. AJP Rep. 2019;9(3):275-291.  https://doi.org/10.1055/s-0039-1695004
  50. Yu GZ, Aye CY, Lewandowski AJ, Davis EF, Khoo CP, Newton L, Yang CT, Al Haj Zen A, Simpson LJ, O’Brien K, Cook DA, Granne I, Kyriakou T, Channon KM, Watt SM, Leeson P. Association of Maternal Antiangiogenic Profile at Birth With Early Postnatal Loss of Microvascular Density in Offspring of Hypertensive Pregnancies. Hypertension. 2016;68(3):749-759.  https://doi.org/10.1161/HYPERTENSIONAHA.116.07586
  51. Timpka S, Macdonald-Wallis C, Hughes AD, Chaturvedi N, Franks PW, Lawlor DA, Fraser A. Hypertensive Disorders of Pregnancy and Offspring Cardiac Structure and Function in Adolescence. J Am Heart Assoc. 2016; 5(11):e003906. https://doi.org/10.1161/JAHA.116.003906
  52. McGinnis R, Steinthorsdottir V, Williams NO, Thorleifsson G, Shooter S, Hjartardottir S, Bumpstead S, Stefansdottir L, Hildyard L, Sigurdsson JK, Kemp JP, Silva GB, Thomsen LCV, Jääskeläinen T, Kajantie E, Chappell S, Kalsheker N, Moffett A, Hiby S, Lee WK, Padmanabhan S, Simpson NAB, Dolby VA, Staines-Urias E, Engel SM, Haugan A, Trogstad L, Svyatova G, Zakhidova N, Najmutdinova D; FINNPEC Consortium; GOPEC Consortium, Dominiczak AF, Gjessing HK, Casas JP, Dudbridge F, Walker JJ, Pipkin FB, Thorsteinsdottir U, Geirsson RT, Lawlor DA, Iversen AC, Magnus P, Laivuori H, Stefansson K, Morgan L. Variants in the fetal genome near FLT1 are associated with risk of preeclampsia. Nat Genet. 2017;49(8): 1255-1260. https://doi.org/10.1038/ng.3895
  53. Martin A, Krishna I, Badell M, Samuel A. Can the quantity of cell-free fetal DNA predict preeclampsia: a systematic review. Prenat Diagn. 2014;34(7): 685-691.  https://doi.org/10.1002/pd.4416
  54. Chappell S, Morgan L. Searching for genetic clues to the causes of pre-eclampsia. Clin Sci (Lond). 2006;110(4):443-458.  https://doi.org/10.1042/CS20050323
  55. Williams PJ, Pipkin BF. The genetics of pre-eclampsia and other hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol. 2011;25(4): 405-417.  https://doi.org/10.1016/j.bpobgyn.2011.02.007
  56. Esplin MS, Fausett MB, Fraser A, Kerber R, Mineau G, Carrillo J, Varner MW. Paternal and maternal components of the predisposition to preeclampsia. N Engl J Med. 2001;344(12):867-872.  https://doi.org/10.1056/NEJM200103223441201
  57. Poon LC, Magee LA, Verlohren S, Shennan A, von Dadelszen P, Sheiner E, Hadar E, Visser G, Da Silva Costa F, Kapur A, McAuliffe F, Nazareth A, Tahlak M, Kihara AB, Divakar H, McIntyre HD, Berghella V, Yang H, Romero R, Nicolaides KH, Melamed N, Hod M. A literature review and best practice advice for second and third trimester risk stratification, monitoring, and management of pre-eclampsia: Compiled by the Pregnancy and Non-Communicable Diseases Committee of FIGO (the International Federation of Gynecology and Obstetrics). Int J Gynaecol Obstet. 2021;154(suppl 1):3-31.  https://doi.org/10.1002/ijgo.13763
  58. Khodzhaeva ZS, Kholin AM, Chulkov VS, Muminova KT. Acetylsalicylic acid in the prevention of preeclampsia and associated obstetric and perinatal complications. Obstetrics and gynecology. 2018;8:12-8. (In Russ.). https://doi.org/10.18565/aig.2018.8.12-18
  59. McNeil JJ, Wolfe R, Woods RL, Tonkin AM, Donnan GA, Nelson MR, Reid CM, Lockery JE, Kirpach B, Storey E, Shah RC, Williamson JD, Margolis KL, Ernst ME, Abhayaratna WP, Stocks N, Fitzgerald SM, Orchard SG, Trevaks RE, Beilin LJ, Johnston CI, Ryan J, Radziszewska B, Jelinek M, Malik M, Eaton CB, Brauer D, Cloud G, Wood EM, Mahady SE, Satterfield S, Grimm R, Murray AM; ASPREE Investigator Group. Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly. N Engl J Med. 2018;379(16):1509-1518. https://doi.org/10.1056/NEJMoa1805819.
  60. Gavrilov DV, Gusev AV, Nikulina AV, Kuznetsova TYu, Drapkina OM. Correctness of cardiovascular risk assessment in daily clinical practice. The Russian Journal of Preventive Medicine. 2021;24(4):69-75. (In Russ.). https://doi.org/10.17116/profmed20212404169

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.